CIPO Patents = 2

EPO Patents = 1

Forward Citations = 12

Loading Chart...

9 inventors (with patents filed for the assignee):

Takenao Odagami (4 out of 10 patents)

Hiroyuki Kouji (4 out of 12 patents)

Michinori Kohara (2 out of 19 patents)

4. Yoichi Ozawa (1 out of 12 patents)

5. Yusaku Hori (1 out of 4 patents)

6. Yuji Kogami (1 out of 7 patents)

7. Yuji Yamamoto (1 out of 17 patents)

8. Kentaro Iso (1 out of 2 patents)

9. Satoshi Inoue (1 out of 78 patents)

10. Inoue Satoshi (1 patent)

11. Yamamoto Yuji (0 patent)

12. Iso Kentaro (0 patent)

13. Yamamoto Yuji (0 patent)

14. Iso Kentaro (0 patent)

5 patents: Sort by Forward Citations

1. 11369623 - Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitor (2022-06-28),

2. 10265331 - Prevention or treatment agent for hepatic fibrosis (2019-04-23),

3. 9700569 - Prevention or treatment agent for hepatic fibrosis (2017-07-11),

4. 9193734 - Alpha helix mimetics and methods relating thereto (2015-11-24),

5. 9174998 - (6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound (2015-11-03),

Prism Pharma Co., Ltd. is a leading pharmaceutical company that specializes in research, development, and manufacturing of innovative healthcare products. With a focus on quality and customer satisfaction, we strive to deliver cutting-edge solutions to improve health and well-being across the globe.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#205 in Kanagawa

#6,491 in Japan

Kanagawa, Japan

Prism Pharma Co., Ltd.

Forward Citations = 12

9 inventors:

Takenao Odagami (4 out of 10 patents)

Hiroyuki Kouji (4 out of 12 patents)

Michinori Kohara (2 out of 19 patents)

4. Yoichi Ozawa (1 out of 12 patents)

5. Yusaku Hori (1 out of 4 patents)

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com